Literature DB >> 27716907

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.

Hervé Ghesquières1,2,3, Beth R Larrabee3, Olivier Casasnovas4, Matthew J Maurer3, James D McKay5, Stephen M Ansell6, Dorothy Montgomery7, Yan W Asmann3, Katrina Farrell7, Aurélie Verney2, Susan L Slager3, Cristine Allmer3, Aurore Perrot8, Richard Delarue9, Thomas M Habermann6, Jehan Dupuis10, Brian K Link11, Danielle Canioni12, Ahmet Dogan13, Wendy Cozen14, Ruth F Jarrett7, James R Cerhan3, Gilles Salles1,2.   

Abstract

Entities:  

Keywords:  zzm321990zzm321990MYCzzm321990zzm321990; zzm321990PVT1zzm321990; Hodgkin lymphoma; polymorphism; prognostic; susceptibility

Mesh：

Substances：

Year:  2016        PMID： 27716907      PMCID： PMC5344766          DOI： 10.1111/bjh.14306

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  p53-Dependent induction of PVT1 and miR-1204.

Authors:  Anthony M Barsotti; Rachel Beckerman; Oleg Laptenko; Konrad Huppi; Natasha J Caplen; Carol Prives
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

2.  Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.

Authors:  Carrie A Thompson; Matthew J Maurer; James R Cerhan; Jerry A Katzmann; Stephen M Ansell; Thomas M Habermann; William R Macon; George J Weiner; Brian K Link; Thomas E Witzig
Journal:  Am J Hematol       Date:  2011-10-17       Impact factor: 10.047

3.  Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.

Authors:  Christoph Renné; Jose Ignacio Martin-Subero; Maren Eickernjäger; Martin-Leo Hansmann; Ralf Küppers; Reiner Siebert; Andreas Bräuninger
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  miR-217 is an oncogene that enhances the germinal center reaction.

Authors:  Virginia G de Yébenes; Nahikari Bartolomé-Izquierdo; Rubén Nogales-Cadenas; Pablo Pérez-Durán; Sonia M Mur; Nerea Martínez; Lorena Di Lisio; Davide F Robbiani; Alberto Pascual-Montano; Marta Cañamero; Miguel A Piris; Almudena R Ramiro
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

5.  Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.

Authors:  René-Olivier Casasnovas; Nicolas Mounier; Pauline Brice; Marine Divine; Franck Morschhauser; Jean Gabarre; Jean-Yves Blay; Laurent Voillat; Pierre Lederlin; Aspasia Stamatoullas; Jacques Bienvenu; Michel Guiguet; Liliane Intrator; Monique Grandjean; Josette Brière; Christophe Ferme; Gilles Salles
Journal:  J Clin Oncol       Date:  2007-03-26       Impact factor: 44.544

6.  Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.

Authors:  Kevin Y Urayama; Ruth F Jarrett; Henrik Hjalgrim; Arjan Diepstra; Yoichiro Kamatani; Amelie Chabrier; Valerie Gaborieau; Anne Boland; Alexandra Nieters; Nikolaus Becker; Lenka Foretova; Yolanda Benavente; Marc Maynadié; Anthony Staines; Lesley Shield; Annette Lake; Dorothy Montgomery; Malcolm Taylor; Karin Ekström Smedby; Rose-Marie Amini; Hans-Olov Adami; Bengt Glimelius; Bjarke Feenstra; Ilja M Nolte; Lydia Visser; Gustaaf W van Imhoff; Tracy Lightfoot; Pierluigi Cocco; Lambertus Kiemeney; Sita H Vermeulen; Ivana Holcatova; Lars Vatten; Gary J Macfarlane; Peter Thomson; David I Conway; Simone Benhamou; Antonio Agudo; Claire M Healy; Kim Overvad; Anne Tjønneland; Beatrice Melin; Federico Canzian; Kay-Tee Khaw; Ruth C Travis; Petra H M Peeters; Carlos A González; José Ramón Quirós; María-José Sánchez; José María Huerta; Eva Ardanaz; Miren Dorronsoro; Françoise Clavel-Chapelon; H Bas Bueno-de-Mesquita; Elio Riboli; Eve Roman; Paolo Boffetta; Silvia de Sanjosé; Diana Zelenika; Mads Melbye; Anke van den Berg; Mark Lathrop; Paul Brennan; James D McKay
Journal:  J Natl Cancer Inst       Date:  2012-01-27       Impact factor: 13.506

7.  A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy.

Authors:  Gregory Papagregoriou; Kamil Erguler; Harsh Dweep; Konstantinos Voskarides; Panayiota Koupepidou; Yiannis Athanasiou; Alkis Pierides; Norbert Gretz; Kyriacos N Felekkis; Constantinos Deltas
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

8.  miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.

Authors:  L Chen; M-H Lü; D Zhang; N-B Hao; Y-H Fan; Y-Y Wu; S-M Wang; R Xie; D-C Fang; H Zhang; C-J Hu; S-M Yang
Journal:  Cell Death Dis       Date:  2014-01-30       Impact factor: 8.469

9.  A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

Authors:  W Cozen; M N Timofeeva; D Li; A Diepstra; D Hazelett; M Delahaye-Sourdeix; C K Edlund; L Franke; K Rostgaard; D J Van Den Berg; V K Cortessis; K E Smedby; S L Glaser; H-J Westra; L L Robison; T M Mack; H Ghesquieres; A E Hwang; A Nieters; S de Sanjose; T Lightfoot; N Becker; M Maynadie; L Foretova; E Roman; Y Benavente; K A Rand; B N Nathwani; B Glimelius; A Staines; P Boffetta; B K Link; L Kiemeney; S M Ansell; S Bhatia; L C Strong; P Galan; L Vatten; T M Habermann; E J Duell; A Lake; R N Veenstra; L Visser; Y Liu; K Y Urayama; D Montgomery; V Gaborieau; L M Weiss; G Byrnes; M Lathrop; P Cocco; T Best; A D Skol; H-O Adami; M Melbye; J R Cerhan; A Gallagher; G M Taylor; S L Slager; P Brennan; G A Coetzee; D V Conti; K Onel; R F Jarrett; H Hjalgrim; A van den Berg; J D McKay
Journal:  Nat Commun       Date:  2014-06-12       Impact factor: 14.919

10.  A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).

Authors:  Victor Enciso-Mora; Peter Broderick; Yussanne Ma; Ruth F Jarrett; Henrik Hjalgrim; Kari Hemminki; Anke van den Berg; Bianca Olver; Amy Lloyd; Sara E Dobbins; Tracy Lightfoot; Flora E van Leeuwen; Asta Försti; Arjan Diepstra; Annegien Broeks; Jayaram Vijayakrishnan; Lesley Shield; Annette Lake; Dorothy Montgomery; Eve Roman; Andreas Engert; Elke Pogge von Strandmann; Katrin S Reiners; Ilja M Nolte; Karin E Smedby; Hans-Olov Adami; Nicola S Russell; Bengt Glimelius; Stephen Hamilton-Dutoit; Marieke de Bruin; Lars P Ryder; Daniel Molin; Karina Meden Sorensen; Ellen T Chang; Malcolm Taylor; Rosie Cooke; Robert Hofstra; Helga Westers; Tom van Wezel; Ronald van Eijk; Alan Ashworth; Klaus Rostgaard; Mads Melbye; Anthony J Swerdlow; Richard S Houlston
Journal:  Nat Genet       Date:  2010-10-31       Impact factor: 38.330
  10 in total
  6 in total

Review 1.  Long noncoding RNAs (lncRNAs) in human lymphomas.

Authors:  Ali Gholami; Khosro Farhadi; Fatemeh Sayyadipour; Masoud Soleimani; Fakhredin Saba
Journal:  Genes Dis       Date:  2021-02-12

Review 2.  LncRNAs in adaptive immunity: role in physiological and pathological conditions.

Authors:  Pedro Faria Zeni; Marek Mraz
Journal:  RNA Biol       Date:  2020-11-09       Impact factor: 4.652

3.  Knockdown of long non-coding RNA PVT1 inhibits the proliferation of Raji cells through cell cycle regulation.

Authors:  Chanli Zheng; Yu Xiao; Yangqiu Li; Dongmei He
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

4.  An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma.

Authors:  Chuiguo Huang; Naijun Yuan; Liying Wu; Xiaofu Wang; Junqiang Dai; Pan Song; Fengxi Li; Changbao Xu; Xinghua Zhao
Journal:  Onco Targets Ther       Date:  2017-08-14       Impact factor: 4.147

Review 5.  Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin.

Authors:  Martina Ghetti; Ivan Vannini; Clelia Tiziana Storlazzi; Giovanni Martinelli; Giorgia Simonetti
Journal:  Mol Cancer       Date:  2020-03-30       Impact factor: 27.401

6.  The association between polymorphism of the long noncoding RNA, Plasmacytoma variant translocation 1, and the risk of gastric cancer.

Authors:  Jae Ho Park; Eun-Heui Jin; Jang Hee Hong; Sang-Il Lee; Jae Kyu Sung
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.